EFNB3 and neoplasm: Silencing of EFNB3 through intra-tumoral injection of siRNA coupled to in vivo transfectant efficiently decreases EphrinB3 expression in tumoral cells and significantly delays tumor growth (Figure 4B and Supplementary Figure 3B).